جام‌دارو

فجام | Stocks - Tehran Stock Exchange (TSE)
تولید سایر محصولات فلزی ساخته شده
Sector:

تولید سایر محصولات فلزی ساخته شده

Market Type:

Stocks

Status:

Authorized

Last Price: 21,630 3.00
Close Price: 21,480

Income Statement

2026/07/20
Fiscal Year 2026/03/2012 Month
2025/07/21
Fiscal Year 2025/03/2012 Month
2024/07/07
Fiscal Year 2024/03/1912 Month

Revenue from Services & Sales

5.278 Trillion3.328 Trillion2.122 Trillion

Total Revenues

5.278 Trillion3.328 Trillion2.122 Trillion

Cost of Goods Sold

2.68 Trillion1.721 Trillion1.322 Trillion

Gross Profit

2.597 Trillion1.608 Trillion800.147 Billion

General & Administrative Expenses

340.69 Billion238.579 Billion141.288 Billion

Net Operating Income & Expenses

63.546 Billion-17.129 Billion836 Million

Operating Profit (Loss)

2.32 Trillion1.352 Trillion659.695 Billion

Profit Before Tax

2.633 Trillion1.432 Trillion696.365 Billion

Tax

429.465 Billion200.78 Billion155.425 Billion

Net Profit (Loss) After Tax

2.204 Trillion1.231 Trillion540.94 Billion

Retained Earnings at Beginning of Period

1.459 Trillion537.322 Billion438.428 Billion

Approved Dividends — Prior Year AGM

-870 Billion-300 Billion-315 Billion

Capital Decrease (Increase) from Accumulated Losses (Retained Earnings)

-200 Billion--100 Billion

Allocable Profit

2.593 Trillion1.468 Trillion564.368 Billion

Legal Reserve

20 Billion8.732 Billion27.047 Billion

Approved Dividends — Current Year

1.98 Trillion870 Billion300 Billion

Retained Earnings at End of Period

593.445 Billion589.454 Billion237.321 Billion